New and Notable Clinical Data and Guideline Updates on Systemic Therapies in Hepatocellular Carcinoma

New and Notable Clinical Data and Guideline Updates on Systemic Therapies in Hepatocellular Carcinoma is organized by National Comprehensive Cancer Network (NCCN).,Description:,The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with hepatocellular carcinoma (HCC).,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Integrate clinical data and consensus guidelines on the use of systemic treatment approaches into practice for patients with early- or intermediate-stage HCC,• Plan evidence-based and guideline-driven individualized care for patients with advanced HCC, both in the frontline and second-line treatment settings,• Select patients who may benefit from ongoing clinical trials based on tumor characteristics, previous treatment, and patient characteristics and preferences,• Evaluate the rationale and available data for immune checkpoint inhibitor-based combinations across the continuum of HCC care,• Develop strategies to identify and mitigate unique adverse events associated with novel targeted therapies in patients with HCC,Additional details will be posted as soon as information is available.